Dr. Vinay Prasad intervened to restrict the approval of COVID-19 vaccines from Novavax and Moderna, opposing staff recommendations for broad use in those 12 and older. He deemed that the risks of vaccination now outweigh potential benefits, considering falling COVID-19 death rates and hospitalization. Prasad's decision reflects a trend under Health Secretary Robert F. Kennedy Jr., who has previously challenged vaccine efficacy. CDC data indicates continued public health risks from COVID-19, particularly for seniors and vulnerable children.
Dr. Vinay Prasad personally intervened to restrict the approval of two COVID-19 vaccines, despite the FDA staff's recommendation for broader approval for those 12 and older.
Prasad argued that the potential harms of vaccination need to be reassessed, pointing out that even rare side effects might now outweigh the benefits of COVID vaccines.
The CDC reported significant COVID-19-related deaths and hospitalizations since the previous fall, asserting that seniors and young children face the highest risks.
Prasad's decision is part of a trend initiated by officials under Health Secretary Robert F. Kennedy Jr., who has previously raised questions about vaccine efficacy.
Collection
[
|
...
]